• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用临床实践指南降低银屑病患者心血管风险

Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.

机构信息

Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.

出版信息

Dermatol Clin. 2024 Jul;42(3):417-428. doi: 10.1016/j.det.2024.02.008. Epub 2024 Feb 26.

DOI:10.1016/j.det.2024.02.008
PMID:38796273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11128720/
Abstract

National guidelines define psoriasis as a risk enhancer for cardiovascular disease and recommend increased monitoring and more intense management of cardiovascular risk factors in these patients, who face an increased burden of cardiovascular disease morbidity and mortality. Screening for modifiable cardiovascular risk factors, including blood pressure, weight, cholesterol, glucose, and smoking, can be efficiently incorporated into routine dermatology clinical practice. Partnerships with primary care providers and preventive cardiologists are essential to improving management of cardiovascular risk in patients with psoriasis.

摘要

国家指南将银屑病定义为心血管疾病的风险增强因素,并建议在这些患者中增加心血管危险因素的监测和更强化的管理,这些患者面临更高的心血管疾病发病率和死亡率。对可改变的心血管危险因素(包括血压、体重、胆固醇、血糖和吸烟)进行筛查,可以有效地纳入皮肤科常规临床实践中。与初级保健提供者和预防心脏病专家建立伙伴关系对于改善银屑病患者的心血管风险管理至关重要。

相似文献

1
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.使用临床实践指南降低银屑病患者心血管风险
Dermatol Clin. 2024 Jul;42(3):417-428. doi: 10.1016/j.det.2024.02.008. Epub 2024 Feb 26.
2
Practical dietary interventions to prevent cardiovascular disease suitable for implementation in primary care: an ADAPTE-guided systematic review of international clinical guidelines.适合在初级保健中实施的预防心血管疾病的实用饮食干预措施:一项基于 ADAPTE 指南的国际临床指南系统评价。
Int J Behav Nutr Phys Act. 2023 Jul 28;20(1):93. doi: 10.1186/s12966-023-01463-9.
3
Acceptability of 'as needed' biologic therapy in psoriasis: insights from a multistakeholder mixed-methods study.“按需”生物疗法治疗银屑病的可接受性:来自多方利益相关者混合方法研究的见解。
Br J Dermatol. 2024 Jul 16;191(2):243-251. doi: 10.1093/bjd/ljae068.
4
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
5
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.基于手机的干预措施,用于提高成年人心血管疾病一级预防中所开药物的依从性。
Cochrane Database Syst Rev. 2018 Jun 22;6(6):CD012675. doi: 10.1002/14651858.CD012675.pub2.
9
Familial Hypercholesterolemia家族性高胆固醇血症
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Psoriasis Beyond the Skin: A Disease With Cardiovascular Risk.银屑病不止于皮肤:一种具有心血管风险的疾病。
Cureus. 2025 Jul 21;17(7):e88464. doi: 10.7759/cureus.88464. eCollection 2025 Jul.
2
Cardiovascular Risk Among Patients With Moderate-to-Severe Plaque Psoriasis in Southern Sri Lanka: A Case-Control Study.斯里兰卡南部中重度斑块状银屑病患者的心血管风险:一项病例对照研究。
Cureus. 2025 May 29;17(5):e85057. doi: 10.7759/cureus.85057. eCollection 2025 May.
3
Psoriasis.银屑病

本文引用的文献

1
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease.专家和患者对改善银屑病患者心血管疾病预防策略的看法。
J Psoriasis Psoriatic Arthritis. 2022 Oct;7(4):174-186. doi: 10.1177/24755303221101848. Epub 2022 Jun 3.
2
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis.生物制剂和小分子治疗免疫介导的炎症性疾病的主要不良心血管事件风险:网络荟萃分析。
Clin Gastroenterol Hepatol. 2024 May;22(5):961-970.e12. doi: 10.1016/j.cgh.2023.09.033. Epub 2023 Oct 10.
3
Nat Rev Dis Primers. 2025 Jun 26;11(1):45. doi: 10.1038/s41572-025-00630-5.
4
Practical Recommendations on Cardiovascular Risk Evaluation in Patients With Psoriasis and Psoriatic Arthritis for Dermatologists, Rheumatologists, and Primary Care Physicians by the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network.银屑病和银屑病关节炎临床多中心推进网络为皮肤科医生、风湿病学家和初级保健医生提供的关于银屑病和银屑病关节炎患者心血管风险评估的实用建议
J Psoriasis Psoriatic Arthritis. 2025 May 28:24755303251337020. doi: 10.1177/24755303251337020.
5
Cardiovascular disease risk in psoriatic disease: mechanisms and implications for clinical practice.银屑病性疾病中的心血管疾病风险:机制及对临床实践的意义
Curr Opin Rheumatol. 2025 Jul 1;37(4):261-268. doi: 10.1097/BOR.0000000000001092. Epub 2025 May 13.
6
Psoriasis and Atherosclerotic CV Disease-Risk Factor or Risk Marker?银屑病与动脉粥样硬化性心血管疾病——风险因素还是风险标志物?
JAMA Cardiol. 2024 Nov 1;9(11):961-963. doi: 10.1001/jamacardio.2024.2868.
7
A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.一种预防银屑病患者心血管事件的护理协调模式:一项多中心试点研究。
J Invest Dermatol. 2024 Jun;144(6):1405-1409.e1. doi: 10.1016/j.jid.2023.12.008. Epub 2024 Jan 4.
The relationship between blood lipid and risk of psoriasis: univariable and multivariable Mendelian randomization analysis.
血脂与银屑病风险的关系:单变量和多变量孟德尔随机分析。
Front Immunol. 2023 Jun 22;14:1174998. doi: 10.3389/fimmu.2023.1174998. eCollection 2023.
4
Regional Variation in Cardiovascular Risk Factor Screening by Dermatologists for Psoriasis Patients in the United States.美国皮肤科医生对银屑病患者进行心血管危险因素筛查的地区差异。
J Invest Dermatol. 2023 Sep;143(9):1816-1819. doi: 10.1016/j.jid.2023.03.1655. Epub 2023 Mar 27.
5
Shared genetic risk factors and causal association between psoriasis and coronary artery disease.银屑病与冠状动脉疾病的共享遗传风险因素和因果关联。
Nat Commun. 2022 Nov 2;13(1):6565. doi: 10.1038/s41467-022-34323-4.
6
Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies.他汀类药物对成人全因死亡率的影响:倾向评分匹配研究的系统评价和荟萃分析
J Clin Med. 2022 Sep 25;11(19):5643. doi: 10.3390/jcm11195643.
7
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial.阿普司特与银屑病患者血管炎症和心脏代谢功能的相关性:VIP-A 期 4 项、开放标签、非随机临床试验。
JAMA Dermatol. 2022 Dec 1;158(12):1394-1403. doi: 10.1001/jamadermatol.2022.3862.
8
Prevalence of cardiovascular risk factors in patients with psoriasis.银屑病患者心血管危险因素的流行情况。
Cent Eur J Public Health. 2022 Jun;30(Supplement):S05-S10. doi: 10.21101/cejph.a6806.
9
Is It Prime Time for Statin Therapy in Psoriasis?银屑病患者使用他汀类药物治疗的时机是否已到?
J Invest Dermatol. 2022 Jun;142(6):1519-1522. doi: 10.1016/j.jid.2022.02.020.
10
Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.银屑病增加不良心血管结局风险:一项新的队列研究系统评价与荟萃分析
Front Cardiovasc Med. 2022 Mar 25;9:829709. doi: 10.3389/fcvm.2022.829709. eCollection 2022.